A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
Louise Cragg1, Bruce R. Blazar1, Todd Defor1, Nikheel Kolatker1, Wesley Miller1, John Kersey1, Norma Ramsay1, Philip McGlave1, Alexandra Filipovich1, Daniel Weisdorf1
1Division of Hematology/Oncology, Virginia Commonwealth University, Richmond, USA